Comparative Pharmacology
Head-to-head clinical analysis: PLASMA LYTE 148 AND DEXTROSE 5 IN PLASTIC CONTAINER versus PLASMA LYTE 56 IN PLASTIC CONTAINER.
Peer-Reviewed Evidence
Head-to-head clinical analysis: PLASMA LYTE 148 AND DEXTROSE 5 IN PLASTIC CONTAINER versus PLASMA LYTE 56 IN PLASTIC CONTAINER.
PLASMA-LYTE 148 AND DEXTROSE 5% IN PLASTIC CONTAINER vs PLASMA-LYTE 56 IN PLASTIC CONTAINER
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Plasma-Lyte 148 and Dextrose 5% is an intravenous solution that provides maintenance fluid, electrolytes, and calories. Dextrose provides energy and prevents ketosis. Plasma-Lyte 148 contains electrolytes (sodium, potassium, magnesium, calcium, chloride, acetate, gluconate) to replace losses and maintain acid-base balance.
PLASMA-LYTE 56 is an isotonic crystalloid solution that provides electrolytes and water to maintain or restore intravascular volume and electrolyte balance. It expands extracellular fluid volume and improves circulation by increasing plasma volume. The solution's electrolyte composition mimics plasma, helping to correct electrolyte deficits and acid-base disturbances.
IV infusion at a rate of 10-20 mL/kg/hour, not to exceed 100 mL/hour in adults without cardiac or renal compromise; adjust based on fluid status and serum electrolytes.
Intravenous infusion; dose depends on fluid and electrolyte needs; typical adult rate: 100-200 mL/hour.
None Documented
None Documented
Not applicable as it is a balanced electrolyte solution with dextrose. Components distribute and are eliminated rapidly; dextrose half-life ~15-30 minutes in normoglycemia.
Not applicable as a fixed value; infused electrolytes distribute and are eliminated according to individual ion kinetics (e.g., sodium t½ ~30 min, chloride t½ ~1–2 h) with rapid redistribution.
Components are excreted renally. Dextrose is metabolized; electrolytes are eliminated via kidneys (sodium, chloride, acetate, gluconate, magnesium, potassium). No biliary or fecal elimination.
Primarily renal; >90% of infused electrolytes are excreted unchanged in urine; fecal elimination negligible (<5%).
Category C
Category C
Intravenous Electrolyte Solution
Intravenous Electrolyte Solution